In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Call for Late-Breaking Science

EHRA 2025, Vienna & Online from 30 March to 1 April


Put the spotlight on your latest science

Beyond your presentation, your late-breaking science will be the focus for press and media, leading experts and industry connections. The people, the recognition, the network and the stage – will all be yours.

Put the spotlight on your latest science

The call for Late-Breaking Science is now open for the following submissions:

  • Late-Breaking Clinical Trial – Reserved for first presentations of the primary endpoint(s) of a new clinical trial
  • Registry - Reserved for presentations of data not previously presented from a new or existing registry
  • Clinical Trial Update - Reserved for presentations of new data or secondary analysis of a trial where the primary data have been presented previously
  • Basic and Translational Late-Breaking Science - Reserved for late submissions of important findings in Basic and Translational Cardiovascular Science

Start your submission now

Submit

You will need to sign in to your MyESC account

Mark your calendar with key dates

Thursday 05 December 2024 - Opening of the online submission service

Friday 24 January 2025, 12:00 noon CET - Submission deadline

Mid February 2025 - Results announcement. An email will also be sent to each submitter

Discover our Late-Breaking Science Programme

Selected Late-Breaking Science trials will be assigned to dedicated sessions.

All presenters will be required to present their research onsite in Vienna.

Each session will be built to give the maximum visibility to the work and the opportunity for exchange and interactions with peers and key opinion leaders.

During these 4 sessions, presenters from around the world will share the very latest results of their trials. Each presentation will be followed by a review from an expert in the field. 

One of the 4 sessions will accommodate Future Late-Breaking Science – a real opportunity to have an overview of ongoing trials!